07583272 · Active · incorporated 15 years, 4 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Series A
Apterna is a preclinical biotechnology company developing precision RNA therapeutics to improve liver function in patients with advanced liver disease.
See the complete cap table with every shareholder, founder tags, dilution across 13 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.